Guiwang Biology

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Guiwang Biology - overview

Established

2016

Location

Zunyi, Guizhou, China

Primary Industry

Agribusiness

About

Based in Zunyi, China and founded in 2016, Guizhou Guiwang Biotechnology Co. , Ltd. , trading as Guiwang Biology, is a company with a complete edible fungi industry chain, integrating edible fungi strain research and development, planting, sales, edible fungi raw materials, and bio-organic fertilizer processing, and is committed to the industrialized cultivation of edible fungi. In November 2025, Guiwang Biology closed a Series A funding from new investor New Supply and Marketing Capital.


The company specializes in the cultivation and distribution of high-quality edible fungi, primarily focusing on three main products: Pleurotus eryngii (king oyster mushrooms), Cordyceps militaris (Cordyceps flowers), and Ganoderma lucidum (deer antler mushrooms). The company generates revenue through direct sales to retailers as well as bulk orders from industrial clients, who utilize the mushrooms in their food products. The funding raised in November 2025 will drive the company's continuous innovation in edible fungi technology research and development and industrial scaling, injecting new momentum into the development of modern agriculture.


Current Investors

New Supply and Marketing Capital

Primary Industry

Agribusiness

Sub Industries

Industrial Machinery, Agribusiness, Crop Production, Farm Support Services

Website

www.guiwangbio.com

Verticals

Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.